A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4) - specific peptides

Tissue Antigens

Volumn 83, Issue 3, 2014, Pages 174-179

  Schittenhelm, R B ^a   Dudek, N L ^a   Croft, N P ^a   Ramarathinam, S H ^a   Purcell, A W ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

04:01; 35:03; Antigen presentation; C1R cells; HLA B; HLA C; HLA Cw4; Immunopeptidome; Mass spectrometry

Indexed keywords

ANTIGEN PRESENTATION; C1R CELLS; HLA-B*35:03; HLA-C*04:01; HLA-CW4; IMMUNOPEPTIDOME; MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; DATABASES, PROTEIN; EPITOPES; HLA-C ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 84894283785     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12282     Document Type: Article

References (30)

1. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011: 11: 823-36.
2. Saunders PM, van Endert P. Running the gauntlet: from peptide generation to antigen presentation by MHC class I. Tissue Antigens 2011: 78: 161-70.
3. Blais ME, Dong T, Rowland-Jones S. HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 2011: 133: 1-7.
4. Butsch Kovacic M, Martin M, Gao X et al. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2005: 14: 2673-7.
5. Rios A, Rodriguez JM, Moya MR et al. Associations of HLA-C alleles with multinodular goiters: study in a population from southeastern Spain. Arch Surg 2006: 141: 123-8.
6. Carrington M, Nelson GW, Martin MP et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999: 283: 1748-52.
7. Leslie A, Matthews PC, Listgarten J et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010: 84: 9879-88.
8. Bihl FK, Loggi E, Chisholm JV 3rd et al. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T-cell expansion and "RecycleSpot". J Transl Med 2005: 3: 20.
9. Dudek NL, Tan CT, Gorasia DG, Croft NP, Illing PT, Purcell AW. Constitutive and inflammatory immunopeptidome of pancreatic beta-cells. Diabetes 2012: 61: 3018-25.
10. Scull KE, Dudek NL, Corbett AJ et al. Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands. Mol Immunol 2012: 51: 136-42.
11. Garcia-Medel N, Sanz-Bravo A, Van Nguyen D et al. Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics 2012: 11: 1416-29.
12. Illing PT, Vivian JP, Dudek NL et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012: 486: 554-8.
13. Edwards PA, Smith CM, Neville AM, O'Hare MJ. A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol 1982: 12: 641-8.
14. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 1987: 138: 1657-9.
15. Zemmour J, Little AM, Schendel DJ, Parham P. The HLA-A, B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 1992: 148: 1941-8.
16. Steinle A, Falk K, Rotzschke O et al. Motif of HLA-B*3503 peptide ligands. Immunogenetics 1996: 43: 105-7.
17. Escobar H, Crockett DK, Reyes-Vargas E et al. Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. J Immunol 2008: 181: 4874-82.
18. Rajagopalan S, Long EO. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 1997: 185: 1523-8.
19. Fan QR, Wiley DC. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J Exp Med 1999: 190: 113-23.
20. Falk K, Rotzschke O, Grahovac B et al. Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A 1993: 90: 12005-9.
21. Buchsbaum S, Barnea E, Dassau L, Beer I, Milner E, Admon A. Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics 2003: 55: 172-6.
22. Yague J, Alvarez I, Rognan D, Ramos M, Vazquez J, de Castro JA. An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivo. J Exp Med 2000: 191: 2083-92.
23. Glithero A, Tormo J, Doering K, Kojima M, Jones EY, Elliott T. The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate. J Biol Chem 2006: 281: 12699-704.
24. Collins EJ, Garboczi DN, Wiley DC. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 1994: 371: 626-9.
25. Probst-Kepper M, Hecht HJ, Herrmann H et al. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J Immunol 2004: 173: 5610-6.
26. Tynan FE, Reid HH, Kjer-Nielsen L et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 2007: 8: 268-76.
27. Nesvizhskii AI, Vitek O, Aebersold R. Analysis and validation of proteomic data generated by tandem mass spectrometry. Nat Methods 2007: 4: 787-97.
28. Tang WH, Shilov IV, Seymour SL. Nonlinear fitting method for determining local false discovery rates from decoy database searches. J Proteome Res 2008: 7: 3661-7.
29. Sennels L, Bukowski-Wills JC, Rappsilber J. Improved results in proteomics by use of local and peptide-class specific false discovery rates. BMC Bioinformatics 2009: 10: 179.
30. Bugawan TL, Klitz W, Blair A, Erlich HA. High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci. Tissue Antigens 2000: 56: 392-404.